HELIX, INC. for HELIX, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
US H 1526 Medicare Hereditary Cancer USH2369 In Vitro Tests US S 765 Hereditary Cancer Genetic Testing Pharmacogenomic testing, insurance coverage opportunities for whole exome sequencing and specific testing for genetic diseases, opportunities to use genetic testing to justify insurance coverage for specific treatments
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Medical/Disease Research/Clinical Labs MED
US S 2640 Disease X Act 2023, viral surveillance in general sequencing as it relates to discovery of Disease X, development of medical counter-measures Oversight of Lab Developed Tests, express legislative authority
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES New | — |
Budget/Appropriations BUD
HR 812 Inflation Reduction Act, including Defense Health, Viral Surveillance funding, COVID Supplemental allocations Consolidated Appropriations Act 2023 and affiliated draft bills, HHS funding, ASPR, AMD
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLI ARTHUR HYKES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.